Adolore Biotherapeutics, Inc.

PRESS RELEASE

published on 05/16/2024 at 16:00, 2 years 4 months ago

Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy (rdHSV-CA8) Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels
Adolore BioTherapeutics announces groundbreaking findings in gene therapy for chronic pain treatment, highlighting the value of non-opioid analgesics and progress with IND-enabling studies

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesics IND-enabling Studies
BRIEF

published on 03/04/2024 at 16:05, 2 years 6 months ago

Adolore BioTherapeutics obtient un brevet américain pour la thérapie génique CA8* dans le traitement de la douleur chronique

Adolore BioTherapeutics Thérapie Génique Traitement De La Douleur Chronique Solutions Sans Opioïdes Délivrance De Brevet
BRIEF

published on 03/04/2024 at 16:05, 2 years 6 months ago

Adolore BioTherapeutics Secures U.S. Patent for CA8* Gene Therapy in Chronic Pain Treatment

Adolore BioTherapeutics Gene Therapy Chronic Pain Treatment Opioid-Free Solutions Patent Issuance
PRESS RELEASE

published on 03/04/2024 at 16:00, 2 years 6 months ago

Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Treat Chronic Pain
Adolore BioTherapeutics licenses patent and CA8* gene therapy technology from the University of Miami for opioid-free chronic pain treatment. Company progresses toward clinical testing and commercialization

University Of Miami Adolore BioTherapeutics Chronic Pain Opioid-free Gene Therapy
PRESS RELEASE

published on 01/30/2024 at 16:00, 2 years 7 months ago

Adolore BioTherapeutics to Present at the 5th Annual National Institutes of Health (NIH) HEAL Initiative Scientific Meeting
Adolore BioTherapeutics will present at the 5th Annual NIH HEAL Initiative Scientific Meeting regarding the gene therapy program for chronic pain associated with knee osteoarthritis. The program is supported by NIH/NINDS HEAL UH3 Award

Adolore BioTherapeutics Chronic Pain NIH HEAL Initiative Gene Therapy Osteoarthritis
PRESS RELEASE

published on 12/05/2023 at 16:30, 2 years 9 months ago

Adolore BioTherapeutics Presents Promising Preclinical Data Supporting Its Innovative Gene Therapy to Treat Chronic Pain
Adolore BioTherapeutics presented preclinical data supporting its innovative CA8* gene therapy as a long-acting local analgesic for chronic osteoarthritis knee pain management, aiming to replace opioids

Adolore BioTherapeutics CA8* Gene Therapy Chronic Pain Opioid-free Preclinical Data
PRESS RELEASE

published on 10/11/2023 at 16:00, 2 years 11 months ago

Adolore BioTherapeutics to Participate at the Virtual Investor Ask the CEO Conference
PRESS RELEASE

published on 10/03/2023 at 15:15, 2 years 11 months ago

NIN/NINDS HEAL Program Grants Prestigious UH3 Award to the University of Miami, Principal Investigator Roy C. Levitt M.D, to Fund Clinical Development of Adolore BioTherapeutics’ Gene Therapy Program for the Treatment of Chronic Osteoarthritis Knee Pain

Published on 09/26/2026 at 01:00, 6 hours 18 minutes ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 6 hours 18 minutes ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 9 hours 3 minutes ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 13 hours 48 minutes ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 16 hours 18 minutes ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

Published on 09/26/2026 at 00:01, 7 hours 17 minutes ago

Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 12 hours 48 minutes ago

029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:15, 13 hours 3 minutes ago

Warren Wise decodes Qiagen’s DNA
Published on 09/25/2026 at 18:00, 13 hours 18 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:30, 13 hours 48 minutes ago

GEVELOT S.A.: Weekly declaration of share buybacks – 09/25/2026 (French only)

View all EQS

Published on 09/26/2026 at 07:00, 18 minutes ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 13 hours 18 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 13 hours 18 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 13 hours 33 minutes ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 13 hours 38 minutes ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE

News